Funding Rounds
Vaxinano Series A Round, October 2024
VaxinanoVaxinano is a prophylactic and therapeutic nasal vaccines developer founded in 2016 by Didier Betbeder.
Summary
Stage: Series A
Raised Amount: $6.50M
Raised Date: 2024-10-30
Stage: Series A
Raised Amount: $6.50M
Raised Date: 2024-10-30